Please Wait.....
Report
MEA Transplant Diagnostics Market - Industry Trends and Forecast to 2029
Market Report I 2022-10-01 I 332 Pages I Data Bridge Market Research
Middle East and Africa transplant diagnostics market is projected to register a CAGR of 4.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2029
Market Segmentation:
Middle East and Africa Transplant Diagnostics Market, By Product Type (Transplant Diagnostic Instrument, Transplant Diagnostic Software, Transplant Diagnostic Reagent), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays), Transplant Type (Solid Organ Transplantation, Stem Cell Transplantation, Soft Tissue Transplantation, Bone Marrow Transplantation, Other Transplants), Application (Diagnostic Applications, Research Applications), End User (Research Laboratories and Academic Institutes, Hospital and Transplant Centers, Commercial Service Providers, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, and the Rest of the Middle East and Africa) Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Middle East and Africa Transplant Diagnostics Market are:
- Increase in the technological advancements in the field of transplant
- Rising use of stem cell theraphy
Market Players:
Some of the major players operating in the Middle East and Africa transplant diagnostics market are:
- Hologic, Inc.
- Biofortuna Limited
- Takara Bio Inc.
- Abbott
- Thermo Fisher Scientific Inc.
- Luminex Corporation (A subsidiary of DiaSorin Company)
- DiaSorin S.p.A.
- Stryker
- Bio-Rad Laboratories, Inc.
- Zimmer Biomet
- QIAGEN
- F. Hoffmann-La Roche Ltd
- BIOMERIEUX
- CareDx Inc.
- Illumina, Inc.
- IMMUCOR
TABLE OF CONTENTS
1 INTRODUCTION 74
1.1 OBJECTIVES OF THE STUDY 74
1.2 MARKET DEFINITION 74
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET 74
1.4 CURRENCY AND PRICING 77
1.5 LIMITATIONS 77
1.6 MARKETS COVERED 77
2 MARKET SEGMENTATION 83
2.1 MARKETS COVERED 83
2.2 GEOGRAPHICAL SCOPE 84
2.3 YEARS CONSIDERED FOR THE STUDY 85
2.4 DBMR TRIPOD DATA VALIDATION MODEL 86
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 89
2.6 MULTIVARIATE MODELLING 90
2.7 MARKET APPLICATION COVERAGE GRID 91
2.8 SOURCE LIFELINE CURVE 92
2.9 DBMR MARKET POSITION GRID 93
2.10 VENDOR SHARE ANALYSIS 94
2.11 SECONDARY SOURCES 95
2.12 ASSUMPTIONS 95
3 EXECUTIVE SUMMARY 96
3.1 EPIDEMOLOGY 100
3.2 PESTEL_ANALYSIS 115
3.3 PORTER'S FIVE FORCE 116
3.4 TECHNOLOGICAL INNOVATIONS 117
4 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET: REGULATIONS 118
5 KEY STRATEGIC INITIATIVES 122
6 INDUSTRIAL INSIGHTS: 123
7 MARKET OVERVIEW 125
7.1 DRIVERS 127
7.1.1 RISING NUMBER OF TRANSPLANT PROCEDURES 127
7.1.2 INCREASE IN THE TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF TRANSPLANTS 127
7.1.3 RISING HEALTHCARE SPENDING 127
7.1.4 ADOPTION OF CROSS-MATCHING AND CHIMERISM TESTING DURING PRE- AND POST-TRANSPLANTATION 128
7.2 RESTRAINTS 128
7.2.1 HIGH COST OF ORGAN TRANSPLANTATION 128
7.2.2 THE RISKS AND DIFFICULTIES OF ORGAN TRANSPLANTATION 128
7.3 OPPORTUNITIES 129
7.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 129
7.3.2 RISE IN PUBLIC, PRIVATE, AND GOVERNMENT FUNDING FOR ORGAN TRANSPLANTATION 129
7.3.3 SURGE IN AWARENESS ABOUT THE IMPORTANCE OF ORGAN TRANSPLANTATION 130
7.4 CHALLENGES 131
7.4.1 ETHICAL CHALLENGES FACED DURING ORGAN TRANSPLANTATION 131
7.4.2 LACK OF ORGAN DONORS OR GAP BETWEEN ORGAN DONORS AND ORGANS NEEDED ANNUALLY 131
8 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE 133
8.1 OVERVIEW 134
8.2 TRANSPLANT DIAGNOSTIC INSTRUMENTS 137
8.2.1 AUTOMATED PIPETTORS & DISPENSERS 137
8.2.2 AUTOMATED SYSTEMS 137
8.2.2.1 NUCLEIC ACID EXTRACTION SYSTEM 138
8.2.2.2 PCR SETUP 138
8.2.2.3 OTHERS 138
8.2.3 NGS INSTRUMENTS 138
8.2.4 READERS & ANALYZERS 138
8.2.5 TRANSPLANT DIAGNOSTIC KITS 138
8.2.5.1 ASPERGILLUS SPP KITS 139
8.2.5.2 P. JIROVECII KITS 139
8.2.5.3 CMV KITS 139
8.2.5.4 EBV KITS 139
8.2.5.5 BKV KITS 140
8.2.5.6 VZV KITS 140
8.2.5.7 HSV1 KITS 140
8.2.5.8 HSV2 KITS 140
8.2.5.9 PARVOVIRUS B19 KITS 140
8.2.5.10 ADENOVIRUS KITS 140
8.2.5.11 ENTEROVIRUS KITS 140
8.2.5.12 JCV KITS 140
8.2.5.13 HHV6 KITS 140
8.2.5.14 HHV7 KITS 140
8.2.5.15 HHV8 KITS 140
8.2.5.16 TOXOPLASMA GONDII KITS 140
8.2.5.17 HEPATITIS E KITS 141
8.2.5.18 OTHER KITS 141
8.2.6 OTHER KITS 141
8.3 TRANSPLANT DIAGNOSTIC SOFTWARE'S 141
8.3.1 DNA SOFTWARE 142
8.3.2 NGS SOFTWARE 142
8.3.3 DATA MANAGEMENT SOFTWARE 142
8.3.4 OTHER SOFTWARE'S 142
8.4 TRANSPLANT DIAGNOSTIC REAGENTS 142
8.4.1 MONOCLONAL ANTIBODIES 143
8.4.2 CYTOTOXIC CONTROLS 143
8.4.3 HUMAN SERUM 143
8.4.4 OTHER REAGENTS 143
9 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY 144
9.1 OVERVIEW 145
9.2 PCR-BASED MOLECULAR ASSAYS 148
9.2.1 REAL TIME PCR 148
9.2.2 SEQUENCE-SPECIFIC PRIMER-PCR 148
9.2.3 SEQUENCE-SPECIFIC OLIGONUCLEOTIDE-PCR 149
9.2.4 RESTRICTION FRAGMENT LENGTH POLYMORPHISM (RFLP) 149
9.2.5 OTHER-PCR BASED MOLECULAR ASSAYS 149
9.3 SEQUENCING-BASED MOLECULAR ASSAYS 149
9.3.1 SANGER SEQUENCING 150
9.3.2 NEXT GENERATION SEQUENCING 150
9.3.3 OTHER SEQUENCING-BASED MOLECULAR ASSAYS. 150
10 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY TRANSPLANT TYPE 151
10.1 OVERVIEW 152
10.2 SOLID ORGAN TRANSPLANTATION 155
10.2.1 KIDNEY TRANSPLANTATION 155
10.2.2 LIVER TRANSPLANTATION 155
10.2.3 HEART TRANSPLANTATION 156
10.2.4 LUNG TRANSPLANTATION 156
10.2.5 PANCREAS TRANSPLANTATION 156
10.2.6 OTHER ORGAN TRANSPLANTATIONS 156
10.3 STEM CELL TRANSPLANTATION 156
10.3.1 BONE MARROW TRANSPLANT (BMT) 157
10.3.2 PERIPHERAL BLOOD STEM CELL TRANSPLANT 157
10.3.3 CORD BLOOD TRANSPLANT 157
10.3.4 OTHER STEM CELL TRANSPLANTS 157
10.4 SOFT TISSUE TRANSPLANTATION 157
10.4.1 SKIN GRAFT 158
10.4.2 CARTILAGE TRANSPLANTATION 158
10.4.3 ADRENAL AUTOGRAFTING 158
10.4.4 OTHER SOFT TISSUE TRANSPLANTATION. 158
10.5 BONE MARROW TRANSPLANTATION 159
10.5.1 AUTOLOGOUS BONE MARROW TRANSPLANT 159
10.5.2 ALLOGENEIC BONE MARROW TRANSPLANT 159
10.5.3 UMBILICAL CORD BLOOD TRANSPLANT. 160
10.6 OTHERS 160
11 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION 161
11.1 OVERVIEW 162
11.2 DIAGNOSTIC APPLICATIONS 165
11.2.1 TRANSPLANT DIAGNOSTIC INSTRUMENT 165
11.2.1.1 AUTOMATED PIPETTORS & DISPENSERS 166
11.2.1.2 AUTOMATED SYSTEMS 166
11.2.1.3 NGS INSTRUMENTS 166
11.2.1.4 READERS & ANALYZERS 166
11.2.1.5 TRANSPLANT DIAGNOSTIC KITS 166
11.2.1.6 OTHERS 166
11.2.2 TRANSPLANT DIAGNOSTIC SOFTWARE 166
11.2.2.1 DNA SOFTWARE 167
11.2.2.2 NGS SOFTWARE 167
11.2.2.3 DATA MANAGEMENT SOFTWARE 167
11.2.2.4 OTHER SOFTWARES 167
11.2.3 TRANSPLANT DIAGNOSTIC REAGENT 167
11.2.3.1 MONOCLONAL ANTIBODIES 168
11.2.3.2 CYTOTOXIC CONTROLS 168
11.2.3.3 HUMAN SERUM 168
11.2.3.4 OTHER REAGENTS 168
11.3 RESEARCH APPLICATIONS 168
11.3.1 TRANSPLANT DIAGNOSTIC INSTRUMENT 169
11.3.1.1 AUTOMATED PIPETTORS & DISPENSERS 170
11.3.1.2 AUTOMATED SYSTEMS 170
11.3.1.3 NGS INSTRUMENTS 170
11.3.1.4 READERS & ANALYZERS 170
11.3.1.5 TRANSPLANT DIAGNOSTIC KITS 170
11.3.1.6 OTHERS 170
11.3.2 TRANSPLANT DIAGNOSTIC SOFTWARE 170
11.3.2.1 DNA SOFTWARE 171
11.3.2.2 NGS SOFTWARE 171
11.3.2.3 DATA MANAGEMENT SOFTWARE 171
11.3.2.4 OTHER SOFTWARES 171
11.3.3 TRANSPLANT DIAGNOSTIC REAGENT 171
11.3.3.1 MONOCLONAL ANTIBODIES 172
11.3.3.2 CYTOTOXIC CONTROLS 172
11.3.3.3 HUMAN SERUM 172
11.3.3.4 OTHER REAGENTS 172
12 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY END USER 173
12.1 OVERVIEW 174
12.2 HOSPITALS AND TRANSPLANT CENTERS 177
12.3 COMMERCIAL SERVICE PROVIDERS 177
12.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 177
12.5 OTHERS 178
13 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 179
13.1 OVERVIEW 180
13.2 DIRECT TENDER 183
13.3 RETAIL SALES 183
13.4 OTHERS 183
14 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET, BY REGION 185
14.1 MIDDLE EAST & AFRICA 186
14.1.1 SOUTH AFRICA 199
14.1.2 SAUDI ARABIA 211
14.1.3 U.A.E 223
14.1.4 EGYPT 235
14.1.5 ISRAEL 247
14.1.6 REST OF MIDDLE EAST AND AFRICA 259
15 MIDDLE EAST & AFRICA TRANSPLANT DIAGNOSTICS MARKET: COMPANY LANDSCAPE 260
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 260
16 SWOT ANALYSIS 261
17 COMPANY PROFILE 262
17.1 ABBOTT 262
17.1.1 COMPANY SNAPSHOT 262
17.1.2 REVENUE ANALYSIS 262
17.1.3 COMPANY SHARE ANALYSIS 263
17.1.4 PRODUCT PORTFOLIO 263
17.1.5 RECENT DEVELOPMENTS 263
17.2 THERMO FISHER SCIENTIFIC INC. 264
17.2.1 COMPANY SNAPSHOT 264
17.2.2 REVENUE ANALYSIS 264
17.2.3 COMPANY SHARE ANALYSIS 265
17.2.4 PRODUCT PORTFOLIO 265
17.2.5 RECENT DEVELOPMENTS 267
17.3 F. HOFFMANN LA ROCHE LTD 268
17.3.1 COMPANY SNAPSHOT 268
17.3.2 REVENUE ANALYSIS 268
17.3.3 COMPANY SHARE ANALYSIS 269
17.3.4 PRODUCT PORTFOLIO 269
17.3.5 RECENT DEVELOPMENT 270
17.4 TAKARA BIO INC. 271
17.4.1 COMPANY SNAPSHOT 271
17.4.2 REVENUE ANALYSIS 271
17.4.3 COMPANY SHARE ANALYSIS 272
17.4.4 PRODUCT PORTFOLIO 272
17.4.5 RECENT DEVELOPMENTS 272
17.5 HOLOGIC, INC 273
17.5.1 COMPANY SNAPSHOT 273
17.5.2 REVENUE ANALYSIS 273
17.5.3 COMPANY SHARE ANALYSIS 274
17.5.4 PRODUCT PORTFOLIO 274
17.5.5 RECENT DEVELOPMENTS 275
17.6 ADAPTIVE BIOTECHNOLOGIES 276
17.6.1 COMPANY SNAPSHOT 276
17.6.2 REVENUE ANALYSIS 276
17.6.3 PRODUCT PORTFOLIO 277
17.6.4 RECENT DEVELOPMENT 277
17.7 ALTONA DIAGNOSTICS 278
17.7.1 COMPANY SNAPSHOT 278
17.7.2 PRODUCT PORTFOLIO 278
17.7.3 RECENT DEVELOPMENTS 278
17.8 ARQUER DIAGNOSTICS LTD 279
17.8.1 COMPANY SNAPSHOT 279
17.8.2 PRODUCT PORTFOLIO 279
17.8.3 RECENT DEVELOPMENTS 280
17.9 BAG DIAGNOSTICS GMBH 281
17.9.1 COMPANY SNAPSHOT 281
17.9.2 PRODUCT PORTFOLIO 281
17.9.3 RECENT DEVELOPMENTS 281
17.10 BIOFORTUNA LIMITED 282
17.10.1 COMPANY SNAPSHOT 282
17.10.2 PRODUCT PORTFOLIO 282
17.10.3 RECENT DEVELOPMENT 282
17.11 BIOMERIEUX 283
17.11.1 COMPANY SNAPSHOT 283
17.11.2 REVENUE ANALYSIS 283
17.11.3 PRODUCT PORTFOLIO 284
17.11.4 RECENT DEVELOPMENTS 284
17.12 BIO-RAD LABORATORIES, INC. 285
17.12.1 COMPANY SNAPSHOT 285
17.12.2 REVENUE ANALYSIS 285
17.12.3 PRODUCT PORTFOLIO 286
17.12.4 RECENT DEVELOPMENT 287
17.13 BIOTYPE GMBH 288
17.13.1 COMPANY SNAPSHOT 288
17.13.2 PRODUCT PORTFOLIO 288
17.13.3 RECENT DEVELOPMENTS 289
17.14 CAREDX INC. 290
17.14.1 COMPANY SNAPSHOT 290
17.14.2 REVENUE ANALYSIS 290
17.14.3 PRODUCT PORTFOLIO 291
17.14.4 RECENT DEVELOPMENTS 293
17.15 CLONIT SRL 294
17.15.1 COMPANY SNAPSHOT 294
17.15.2 PRODUCT PORTFOLIO 294
17.15.3 RECENT DEVELOPMENT 296
17.16 DIAGNOSTICA LONGWOOD SL 297
17.16.1 COMPANY SNAPSHOT 297
17.16.2 PRODUCT PORTFOLIO 297
17.16.3 RECENT DEVELOPMENTS 297
17.17 DIASORIN S.P.A. 298
17.17.1 COMPANY SNAPSHOT 298
17.17.2 REVENUE ANALYSIS 298
17.17.3 PRODUCT PORTFOLIO 299
17.17.4 RECENT DEVELOPMENT 299
17.18 ELITECHGROUP 300
17.18.1 COMPANY SNAPSHOT 300
17.18.2 PRODUCT PORTFOLIO 300
17.18.3 RECENT DEVELOPMENTS 300
17.19 EUROFINS VIRACOR 301
17.19.1 COMPANY SNAPSHOT 301
17.19.2 PRODUCT PORTFOLIO 301
17.19.3 RECENT DEVELOPMENTS 302
17.20 HORIBA LTD 303
17.20.1 COMPANY SNAPSHOT 303
17.20.2 REVENUE ANALYSIS 303
17.20.3 PRODUCT PORTFOLIO 304
17.20.4 RECENT DEVELOPMENT 304
17.21 ILLUMINA, INC. 305
17.21.1 COMPANY SNAPSHOT 305
17.21.2 REVENUE ANALYSIS 305
17.21.3 PRODUCT PORTFOLIO 306
17.21.4 RECENT DEVELOPMENTS 306
17.22 IMMUCOR 307
17.22.1 COMPANY SNAPSHOT 307
17.22.2 PRODUCT PORTFOLIO 307
17.22.3 RECENT DEVELOPMENTS 307
17.23 LABORATORY CORPORATION OF AMERICA HOLDINGS. 308
17.23.1 COMPANY SNAPSHOT 308
17.23.2 REVENUE ANALYSIS 308
17.23.3 PRODUCT PORTFOLIO 309
17.23.4 RECENT DEVELOPMENTS 310
17.24 LUMINEX CORPORATION. (A SUBSIDIARY OF DIASORIN) 311
17.24.1 COMPANY SNAPSHOT 311
17.24.2 REVENUE ANALYSIS 311
17.24.3 PRODUCT PORTFOLIO 312
17.24.4 RECENT DEVELOPMENT 312
17.25 NANOSTRING 313
17.25.1 COMPANY SNAPSHOT 313
17.25.2 REVENUE ANALYSIS 313
17.25.3 PRODUCT PORTFOLIO 314
17.25.4 RECENT DEVELOPMENT 314
17.26 PATHONOSTICS 315
17.26.1 COMPANY SNAPSHOT 315
17.26.2 PRODUCT PORTFOLIO 315
17.26.3 RECENT DEVELOPMENTS 315
17.27 PRESERVATION SOLUTIONS, INC. 316
17.27.1 COMPANY SNAPSHOT 316
17.27.2 PRODUCT PORTFOLIO 316
17.27.3 RECENT DEVELOPMENTS 316
17.28 QIAGEN 317
17.28.1 COMPANY SNAPSHOT 317
17.28.2 REVENUE ANALYSIS 317
17.28.3 PRODUCT PORTFOLIO 318
17.28.4 RECENT DEVELOPMENTS 319
17.29 RANDOX LABORATORIES LTD. 320
17.29.1 COMPANY SNAPSHOT 320
17.29.2 PRODUCT PORTFOLIO 320
17.29.3 RECENT DEVELOPMENTS 321
17.30 STRYKER 322
17.30.1 COMPANY SNAPSHOT 322
17.30.2 REVENUE ANALYSIS 322
17.30.3 PRODUCT PORTFOLIO 323
17.30.4 RECENT DEVELOPMENT 323
17.31 TRANSMEDICS 324
17.31.1 COMPANY SNAPSHOT 324
17.31.2 REVENUE ANALYSIS 324
17.31.3 PRODUCT PORTFOLIO 325
17.31.4 RECENT DEVELOPMENTS 325
17.32 TRANSONIC. 326
17.32.1 COMPANY SNAPSHOT 326
17.32.2 PRODUCT PORTFOLIO 326
17.32.3 RECENT DEVELOPMENT 326
17.33 ZIMMER BIOMET 327
17.33.1 COMPANY SNAPSHOT 327
17.33.2 REVENUE ANALYSIS 327
17.33.3 PRODUCT PORTFOLIO 328
17.33.4 RECENT DEVELOPMENTS 328
18 QUESTIONNAIRE 329
19 RELATED REPORTS 332
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security